Blood:JAK2ex13Del驱动致癌转化,与慢性嗜酸性白血病和真性红细胞增多症相关

2019-10-15 QQY MedSci原创

JAK2的JH2区域的V617F突变是几种骨髓增生性肿瘤(MPNs)的致癌驱动因素,包括原发性血小板增多症、骨髓纤维化和真性红细胞增多症(PV)。在MPNs中也发现了JAK2的其他图标,最显著的是真性红细胞增多症中的12号外显子突变。现研究人员报到了一个新的复发性突变,在JAK2的JH2结构域中,缺失了4个氨基酸,并插入了一个可变氨基酸(Leu583-Ala586DelInsSer/Gln/Pro

JAK2的JH2区域的V617F突变是几种骨髓增生性肿瘤(MPNs)的致癌驱动因素,包括原发性血小板增多症、骨髓纤维化和真性红细胞增多症(PV)。在MPNs中也发现了JAK2的其他图标,最显著的是真性红细胞增多症中的12号外显子突变。

现研究人员报到了一个新的复发性突变,在JAK2的JH2结构域中,缺失了4个氨基酸,并插入了一个可变氨基酸(Leu583-Ala586DelInsSer/Gln/Pro)。所有4位携带该突变的患者均罹患嗜酸性粒细胞增多症,而且两位携带Leu583-Ala586DelInsSer突变的患者还符合PV和慢性嗜酸性粒细胞白血病(CEL)的诊断标准。

计算和功能性研究表明Leu583-Ala586DelInsSer(简称JAK2ex13InDel)可通过一个类似于JAK2V617F的机制下调JAK2,激活STAT5和ERK,并将亲本Ba/F3细胞转化为生长因子独立性。与JAK2V617F相反, JAK2ex13InDel 不需要外源性同型二聚体1型细胞因子受体来转化Ba/F3细胞,并可在缺乏配体的情况下激活β常链家族细胞因子受体(IL-3R、IL-5R、粒细胞集落刺激因子受体)信号,与嗜酸性粒细胞的临床表型一致。

认识到这种新的PV/CEL重叠型MPN具有重要的临床意义,因为PV和CEL患者都具有高血栓形成风险,可能需要同时减少红细胞、中性粒细胞和嗜酸性粒细胞的数量来预防血栓栓塞事件。对原因不明的嗜酸性粒细胞增多症患者的髓系恶性肿瘤中反复突变的基因进行二代靶向测序或可揭示更多的Leu583-Ala586DelInsSer/Gln/Pro病例,从而促进完善这种特殊MPN的表征。

原始出处:

Ami B Patel, et al.JAK2ex13InDeldrives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.Blood.2019001385.https://doi.org/10.1182/blood.2019001385

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1738016, encodeId=f4351e380165e, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10215, encryptionId=0abd10215e0, topicName=JAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8634348903, createdName=肉我只吃一口, createdTime=Tue Nov 19 18:07:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282047, encodeId=6123128204e66, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336140, encodeId=07071336140ee, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370991, encodeId=0aeb13e0991e0, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488891, encodeId=50fa148889119, content=<a href='/topic/show?id=f9941022ee8' target=_blank style='color:#2F92EE;'>#JAK2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10227, encryptionId=f9941022ee8, topicName=JAK2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=666c8479565, createdName=gao_jian4220, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555465, encodeId=2116155546523, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77158, encryptionId=f016e71581b, topicName=红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1014606284, createdName=linlin2317, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1738016, encodeId=f4351e380165e, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10215, encryptionId=0abd10215e0, topicName=JAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8634348903, createdName=肉我只吃一口, createdTime=Tue Nov 19 18:07:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282047, encodeId=6123128204e66, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336140, encodeId=07071336140ee, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370991, encodeId=0aeb13e0991e0, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488891, encodeId=50fa148889119, content=<a href='/topic/show?id=f9941022ee8' target=_blank style='color:#2F92EE;'>#JAK2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10227, encryptionId=f9941022ee8, topicName=JAK2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=666c8479565, createdName=gao_jian4220, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555465, encodeId=2116155546523, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77158, encryptionId=f016e71581b, topicName=红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1014606284, createdName=linlin2317, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1738016, encodeId=f4351e380165e, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10215, encryptionId=0abd10215e0, topicName=JAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8634348903, createdName=肉我只吃一口, createdTime=Tue Nov 19 18:07:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282047, encodeId=6123128204e66, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336140, encodeId=07071336140ee, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370991, encodeId=0aeb13e0991e0, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488891, encodeId=50fa148889119, content=<a href='/topic/show?id=f9941022ee8' target=_blank style='color:#2F92EE;'>#JAK2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10227, encryptionId=f9941022ee8, topicName=JAK2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=666c8479565, createdName=gao_jian4220, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555465, encodeId=2116155546523, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77158, encryptionId=f016e71581b, topicName=红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1014606284, createdName=linlin2317, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1738016, encodeId=f4351e380165e, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10215, encryptionId=0abd10215e0, topicName=JAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8634348903, createdName=肉我只吃一口, createdTime=Tue Nov 19 18:07:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282047, encodeId=6123128204e66, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336140, encodeId=07071336140ee, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370991, encodeId=0aeb13e0991e0, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488891, encodeId=50fa148889119, content=<a href='/topic/show?id=f9941022ee8' target=_blank style='color:#2F92EE;'>#JAK2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10227, encryptionId=f9941022ee8, topicName=JAK2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=666c8479565, createdName=gao_jian4220, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555465, encodeId=2116155546523, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77158, encryptionId=f016e71581b, topicName=红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1014606284, createdName=linlin2317, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2019-10-17 jambiya
  5. [GetPortalCommentsPageByObjectIdResponse(id=1738016, encodeId=f4351e380165e, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10215, encryptionId=0abd10215e0, topicName=JAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8634348903, createdName=肉我只吃一口, createdTime=Tue Nov 19 18:07:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282047, encodeId=6123128204e66, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336140, encodeId=07071336140ee, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370991, encodeId=0aeb13e0991e0, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488891, encodeId=50fa148889119, content=<a href='/topic/show?id=f9941022ee8' target=_blank style='color:#2F92EE;'>#JAK2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10227, encryptionId=f9941022ee8, topicName=JAK2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=666c8479565, createdName=gao_jian4220, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555465, encodeId=2116155546523, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77158, encryptionId=f016e71581b, topicName=红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1014606284, createdName=linlin2317, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2019-10-17 gao_jian4220
  6. [GetPortalCommentsPageByObjectIdResponse(id=1738016, encodeId=f4351e380165e, content=<a href='/topic/show?id=0abd10215e0' target=_blank style='color:#2F92EE;'>#JAK#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10215, encryptionId=0abd10215e0, topicName=JAK)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e8634348903, createdName=肉我只吃一口, createdTime=Tue Nov 19 18:07:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282047, encodeId=6123128204e66, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336140, encodeId=07071336140ee, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370991, encodeId=0aeb13e0991e0, content=<a href='/topic/show?id=9c39864991e' target=_blank style='color:#2F92EE;'>#致癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86499, encryptionId=9c39864991e, topicName=致癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488891, encodeId=50fa148889119, content=<a href='/topic/show?id=f9941022ee8' target=_blank style='color:#2F92EE;'>#JAK2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10227, encryptionId=f9941022ee8, topicName=JAK2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=666c8479565, createdName=gao_jian4220, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555465, encodeId=2116155546523, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77158, encryptionId=f016e71581b, topicName=红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1014606284, createdName=linlin2317, createdTime=Thu Oct 17 14:07:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]

相关资讯

Stem cells:JAK2V617F突变型巨核细胞可通过促血小板生成素/MPL信号促进造血干/祖细胞扩增

骨髓增生性肿瘤(MPNs)是以造血干细胞/祖细胞(HSPC)扩增和成熟血细胞过度产生为特征的干细胞疾病。获得性激酶突变JAK2V617F在这类疾病中发挥重要作用。HSPC在MPNs中的扩增机制尚未完全明确,限制了治疗措施的疗效。MPNs患者的一个显著特征是巨核细胞(MK)增生。zhangyu等人既往发现JAK2V617F突变型MKs可导致小鼠罹患骨髓增生异常综合征,伴随HSPC扩增。现其再次发现J

Blood:JAK2 V617F和CALR突变的人群发生率和表现

JAK2 V617F和calrenetin突变(CALR)是骨髓增生性肿瘤(MPN)中常见的驱动突变。在普通人群中可检测到JAK2 V617F,但尚无研究调查CALR的发生率。Sabrina Cordua等人开展研究来明确CALR和JAK2 V617F的人群发生率,同时评估有携带这两个突变的MPN患者和非MPN患者的生化特征和生活方式风险因素。2010年-2013年,共招募了19 958位受试者,

FDA批准Celgene的JAK2抑制剂Inrebic治疗骨髓纤维化

FDA近日批准了Celgene的JAK2抑制剂Inrebic(fedratinib)治疗高危原发性或继发性骨髓纤维化的成人患者。这项批准得益于III期JAKARTA研究的数据,其涉及608例骨髓纤维化患者。

Blood:JAK2突变型造血细胞的代谢变化可作为MPN的治疗靶点

能量需求增多和代谢重编程是癌细胞的特征。Tata Nageswara Rao等人发现造血细胞的代谢改变是JAK2突变驱动骨髓增生性肿瘤(MPNs)发病的机制基础。研究人员还发现突变体JAK2的表达增强并破坏了MPN细胞的代谢活性,导致体内的系统代谢改变,包括低血糖、脂肪组织萎缩和早期死亡。在MPN小鼠模型中,低血糖与高活性红细胞生成有关,这是由于糖酵解和氧化磷酸化增强共同作用的结果。通过高脂饮食调

NEJM:骨髓增生性肿瘤的分类及个体化预后

研究人员通过综合基因组特征识别了不同的遗传亚类,并根据因果生物学机制对骨髓增生性肿瘤进行了分类。将基因组数据与临床变量相结合,可以对患者的预后进行个性化预测,并可能为治疗骨髓增生性肿瘤提供支持

CLIN CANCER RES:MET致癌活化和JAK2失活会影响肺癌PD-L1表达

PD-L1和PD-1等免疫检查点阻断疗法正在几种恶性肿瘤中进行研究。CLIN CANCER RES近期发表了一篇文章,研究肺遗传学对肿瘤细胞逃脱免疫监视检查点的作用。